2BB score and signals
Greenwich LifeSciences, Inc.’s current 2BB score is 21 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 50 | Stable |
| Quality | 20 | Weak |
2BBBullish & Bearish
Greenwich LifeSciences, Inc. (GLSI) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 21 out of 100.
Greenwich LifeSciences, Inc.’s current 2BB score is 21 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 50 | Stable |
| Quality | 20 | Weak |
| Headquarters | Stafford, Texas, United States |
| Founded | 2006 |
| Employees | 4 |
| 52-week range | $7.78 – $34.10 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-12 | — | -0.3417 | — | $0.00 |
| 2026-08-12 | — | -0.3366 | — | $0.00 |
| 2026-05-18 | — | -0.3366 | — | $0.00 |
| 2026-04-13 | — | -0.3264 | — | $0.00 |